Quest Diagnostics Incorporated Stock Performance
| DGX Stock | USD 138.42 0.26 0.19% |
Quest Diagnostics has a performance score of 6 on a scale of 0 to 100. The company holds a Beta of 0.0065, which implies not very significant fluctuations relative to the market. As returns on the market increase, Quest Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Quest Diagnostics is expected to be smaller as well. Quest Diagnostics right now holds a risk of 1.31%. Please check Quest Diagnostics maximum drawdown, and the relationship between the information ratio and expected short fall , to decide if Quest Diagnostics will be following its historical price patterns.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Quest Diagnostics Incorporated are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Quest Diagnostics may actually be approaching a critical reversion point that can send shares even higher in June 2024. ...more
Actual Historical Performance (%)
One Day Return 0.19 | Five Day Return 1.29 | Year To Date Return (1.70) | Ten Year Return 141.99 | All Time Return 3.9 K |
Forward Dividend Yield 0.0217 | Payout Ratio 0.3307 | Last Split Factor 2:1 | Forward Dividend Rate 3 | Dividend Date 2024-04-22 |
1 | Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay | 04/02/2024 |
| Quest Diagnostics dividend paid on 22nd of April 2024 | 04/22/2024 |
3 | Quest Diagnostics stock target raised on strong performance | 04/24/2024 |
4 | Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration to Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness... | 04/26/2024 |
5 | FDA finalizes lab developed test rule despite industry opposition | 04/29/2024 |
6 | FDA defends LDT final rule, while critics fear it upends lab industry | 04/30/2024 |
7 | Quest Diagnostics executive sells 246,400 in company stock | 05/01/2024 |
8 | Quest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community | 05/02/2024 |
9 | Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis Forms Licensing Agreements With PathAI | 05/06/2024 |
10 | Quest Diagnostics Grows in Digital Pathology With New Deal | 05/07/2024 |
11 | Helping To Change Perceptions of Bloodwork by Being Phenomenal | 05/08/2024 |
| Begin Period Cash Flow | 315 M |
Quest |
Quest Diagnostics Relative Risk vs. Return Landscape
If you would invest 12,927 in Quest Diagnostics Incorporated on February 11, 2024 and sell it today you would earn a total of 915.00 from holding Quest Diagnostics Incorporated or generate 7.08% return on investment over 90 days. Quest Diagnostics Incorporated is generating 0.1153% of daily returns assuming volatility of 1.3095% on return distribution over 90 days investment horizon. In other words, 11% of stocks are less volatile than Quest, and above 98% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Quest Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Quest Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Quest Diagnostics Incorporated, and traders can use it to determine the average amount a Quest Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.088
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | DGX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.31 actual daily | 11 89% of assets are more volatile |
Expected Return
| 0.12 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Quest Diagnostics is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Quest Diagnostics by adding it to a well-diversified portfolio.
Quest Diagnostics Fundamentals Growth
Quest Stock prices reflect investors' perceptions of the future prospects and financial health of Quest Diagnostics, and Quest Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quest Stock performance.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.062 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 20.34 B | ||||
| Shares Outstanding | 111.09 M | ||||
| Price To Earning | 14.57 X | ||||
| Price To Book | 2.26 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 9.25 B | ||||
| Gross Profit | 3.47 B | ||||
| EBITDA | 1.26 B | ||||
| Net Income | 850 M | ||||
| Cash And Equivalents | 315 M | ||||
| Cash Per Share | 6.15 X | ||||
| Total Debt | 5.37 B | ||||
| Debt To Equity | 0.73 % | ||||
| Current Ratio | 1.46 X | ||||
| Book Value Per Share | 57.95 X | ||||
| Cash Flow From Operations | 1.27 B | ||||
| Earnings Per Share | 7.43 X | ||||
| Market Capitalization | 15.35 B | ||||
| Total Asset | 14.02 B | ||||
| Retained Earnings | 8.82 B | ||||
| Working Capital | 557 M | ||||
| Current Asset | 1.5 B | ||||
| Current Liabilities | 1.17 B | ||||
About Quest Diagnostics Performance
To evaluate Quest Diagnostics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Quest Diagnostics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Quest Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Quest Diagnostics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Quest's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 11.02 | 10.21 | |
| Return On Tangible Assets | 0.17 | 0.14 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.06 | 0.04 | |
| Return On Equity | 0.14 | 0.08 |
Things to note about Quest Diagnostics performance evaluation
Checking the ongoing alerts about Quest Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Quest Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Quest Diagnostics has a strong financial position based on the latest SEC filings | |
| Over 92.0% of the company shares are held by institutions such as insurance companies | |
| On 22nd of April 2024 Quest Diagnostics paid $ 0.75 per share dividend to its current shareholders | |
| Latest headline from accesswire.com: Helping To Change Perceptions of Bloodwork by Being Phenomenal |
- Analyzing Quest Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quest Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Quest Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Quest Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quest Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Quest Diagnostics' stock. These opinions can provide insight into Quest Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Quest Diagnostics information on this page should be used as a complementary analysis to other Quest Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Complementary Tools for Quest Stock analysis
When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Quest Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quest Diagnostics. If investors know Quest will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quest Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 2.88 | Earnings Share 7.43 | Revenue Per Share 83.105 | Quarterly Revenue Growth 0.015 |
The market value of Quest Diagnostics is measured differently than its book value, which is the value of Quest that is recorded on the company's balance sheet. Investors also form their own opinion of Quest Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Quest Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quest Diagnostics' market value can be influenced by many factors that don't directly affect Quest Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quest Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Quest Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quest Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.